{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:42:53Z","timestamp":1773970973127,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T00:00:00Z","timestamp":1672790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Klin Intensivmed Notfmed"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1007\/s00063-022-00976-8","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T16:04:41Z","timestamp":1672848281000},"page":"163-171","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Volumen- und vasoaktive Therapie bei Sepsis","Fluid and vasopressor therapy in sepsis"],"prefix":"10.1007","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2345-756X","authenticated-orcid":false,"given":"Sirak","family":"Petros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,4]]},"reference":[{"key":"976_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13054-018-2102-1","volume":"22","author":"S Lambden","year":"2018","unstructured":"Lambden\u00a0S, Creagh-Brown\u00a0BC, Hunt\u00a0J et al (2018) Definitions and pathophysiology of vasoplegic shock. Crit Care 22:174","journal-title":"Crit Care"},{"key":"976_CR2","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s001340050372","volume":"23","author":"J Poelaert","year":"1997","unstructured":"Poelaert\u00a0J, Declerck\u00a0C, Vogelaers\u00a0D et\u00a0al (1997) Left ventricular systolic and diastolic function in septic shock. Intensive Care Med 23:553\u2013560","journal-title":"Intensive Care Med"},{"key":"976_CR3","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1007\/s00134-015-3748-7","volume":"41","author":"F Sanfilippo","year":"2015","unstructured":"Sanfilippo\u00a0F, Corredor\u00a0C, Fletcher\u00a0N et al (2015) Diastolic dysfunction and mortality in septic patients: a\u00a0systematic review and meta-analysis. Intensive Care Med 41:1004\u20131013","journal-title":"Intensive Care Med"},{"key":"976_CR4","doi-asserted-by":"publisher","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","volume":"49","author":"L Evans","year":"2021","unstructured":"Evans\u00a0L, Rhodes\u00a0A, Alhazzani\u00a0W et\u00a0al (2021) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med 49:e1063\u2013e1143","journal-title":"Crit Care Med"},{"key":"976_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1378\/chest.15-0445","volume":"148","author":"MR Lammi","year":"2015","unstructured":"Lammi\u00a0MR, Aiello\u00a0B, Burg\u00a0GT et\u00a0al (2015) Response to fluid boluses in the fluid and catheter treatment trial. Chest 148:919\u2013926","journal-title":"Chest"},{"key":"976_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1751143720914229","volume":"22","author":"A Simpson","year":"2021","unstructured":"Simpson\u00a0A, Puxty\u00a0K, Mcloone\u00a0P et al (2021) Comorbidity and survival after admission to the intensive care unit: a population-based study of 41,230\u00a0patients. J\u00a0Intensive Care Soc 22:143\u2013151","journal-title":"J Intensive Care Soc"},{"key":"976_CR7","doi-asserted-by":"publisher","first-page":"R45","DOI":"10.1186\/cc7768","volume":"13","author":"SM Bagshaw","year":"2009","unstructured":"Bagshaw\u00a0SM, Webb\u00a0SA, Delaney\u00a0A et al (2009) Very old patients admitted to intensive care in Australia and New Zealand: a\u00a0multi-centre cohort analysis. Crit Care 13:R45","journal-title":"Crit Care"},{"key":"976_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13613-016-0216-7","volume":"6","author":"X Monnet","year":"2016","unstructured":"Monnet\u00a0X, Marik\u00a0PE, Teboul\u00a0JL (2016) Prediction of fluid responsiveness: an update. Ann Intensive Care 6:111","journal-title":"Ann Intensive Care"},{"key":"976_CR9","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/CCM.0b013e31820edcf0","volume":"39","author":"X Monnet","year":"2011","unstructured":"Monnet\u00a0X, Letierce\u00a0A, Hamzaoui\u00a0O et\u00a0al (2011) Arterial pressure allows monitoring the changes in cardiac output induced by volume expansion but not by norepinephrine. Crit Care Med 39:1394\u20131399","journal-title":"Crit Care Med"},{"key":"976_CR10","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1097\/CCM.0b013e318275cece","volume":"41","author":"X Monnet","year":"2013","unstructured":"Monnet\u00a0X, Julien\u00a0F, Ait-Hamou\u00a0N et al (2013) Lactate and venoarterial carbon dioxide difference\/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders. Crit Care Med 41:1412\u20131420","journal-title":"Crit Care Med"},{"key":"976_CR11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1056\/NEJMoa1711584","volume":"378","author":"MW Semler","year":"2018","unstructured":"Semler\u00a0MW, Self\u00a0WH, Wanderer\u00a0JP et\u00a0al (2018) Balanced crystalloids versus saline in critically ill adults. N\u00a0Engl J Med 378:829\u2013839","journal-title":"N Engl J Med"},{"key":"976_CR12","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jama.2021.11684","volume":"326","author":"FG Zampieri","year":"2021","unstructured":"Zampieri\u00a0FG, Machado\u00a0FR, Biondi\u00a0RS et\u00a0al (2021) Effect of intravenous fluid treatment with a\u00a0balanced solution vs 0.9\u202f% saline solution on mortality in critically ill patients: the BaSICS randomized clinical trial. JAMA 326:818\u2013829","journal-title":"JAMA"},{"key":"976_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1056\/NEJMoa2114464","volume":"386","author":"S Finfer","year":"2022","unstructured":"Finfer\u00a0S, Micallef\u00a0S, Hammond\u00a0N et\u00a0al (2022) Balanced multielectrolyte solution versus saline in critically ill adults. N\u00a0Engl J Med 386:815\u2013826","journal-title":"N Engl J Med"},{"key":"976_CR14","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100010","author":"NE Hammond","year":"2022","unstructured":"Hammond\u00a0NE, Zampieri\u00a0FG, Di Tanna\u00a0GL et al (2022) Balanced crystalloids versus saline in critically ill adults\u2014a systematic review and meta-analysis. NEJM Evid. https:\/\/doi.org\/10.1056\/EVIDoa2100010","journal-title":"NEJM Evid"},{"key":"976_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/bja\/aer515","volume":"108","author":"TE Woodcock","year":"2012","unstructured":"Woodcock\u00a0TE, Woodcock\u00a0TM (2012) Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 108:384\u2013394","journal-title":"Br J Anaesth"},{"key":"976_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","volume":"23","author":"R Uchimido","year":"2019","unstructured":"Uchimido\u00a0R, Schmidt\u00a0EP, Shapiro\u00a0NI (2019) The glycocalyx: a\u00a0novel diagnostic and therapeutic target in sepsis. Crit Care 23:16","journal-title":"Crit Care"},{"key":"976_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13054-019-2534-2","volume":"23","author":"JA Hippensteel","year":"2019","unstructured":"Hippensteel\u00a0JA, Uchimido\u00a0R, Tyler\u00a0PD et\u00a0al (2019) Intravenous fluid resuscitation is associated with septic endothelial glycocalyx degradation. Crit Care 23:259","journal-title":"Crit Care"},{"key":"976_CR18","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1007\/s00063-021-00878-1","volume":"116","author":"S John","year":"2021","unstructured":"John\u00a0S (2021) Volumenmanagement im Schock: Neue Ziele in der ersten Schockphase. Med Klin Intensivmed Notfmed 116:636\u2013647","journal-title":"Med Klin Intensivmed Notfmed"},{"key":"976_CR19","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1056\/NEJMoa2202707","volume":"386","author":"TS Meyhoff","year":"2022","unstructured":"Meyhoff\u00a0TS, Hjortrup\u00a0PB, Wetterslev\u00a0J et\u00a0al (2022) Restriction of intravenous fluid in ICU patients with septic shock. N\u00a0Engl J Med 386:2459\u20132470","journal-title":"N Engl J Med"},{"key":"976_CR20","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1097\/CCM.0000000000002189","volume":"45","author":"Y Sakr","year":"2017","unstructured":"Sakr\u00a0Y, Rubatto Birri\u00a0PN, Kotfis\u00a0K et\u00a0al (2017) Higher fluid balance increases the risk of death from sepsis: results from a\u00a0large international audit. Crit Care Med 45:386\u2013394","journal-title":"Crit Care Med"},{"key":"976_CR21","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1161\/01.CIR.95.5.1122","volume":"95","author":"DW Landry","year":"1997","unstructured":"Landry\u00a0DW, Levin\u00a0HR, Gallant\u00a0EM et\u00a0al (1997) Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 95:1122\u20131125","journal-title":"Circulation"},{"key":"976_CR22","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1097\/00003246-200109000-00016","volume":"29","author":"M Bucher","year":"2001","unstructured":"Bucher\u00a0M, Hobbhahn\u00a0J, Kurtz\u00a0A (2001) Nitric oxide-dependent down-regulation of angiotensin II type 2 receptors during experimental sepsis. Crit Care Med 29:1750\u20131755","journal-title":"Crit Care Med"},{"key":"976_CR23","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/cc12809","volume":"17","author":"K Mederle","year":"2013","unstructured":"Mederle\u00a0K, Schweda\u00a0F, Kattler\u00a0V et al (2013) The angiotensin II AT1 receptor-associated protein Arap1 is involved in sepsis-induced hypotension. Crit Care 17:R130","journal-title":"Crit Care"},{"key":"976_CR24","doi-asserted-by":"publisher","first-page":"R97","DOI":"10.1186\/cc13868","volume":"18","author":"V Beck","year":"2014","unstructured":"Beck\u00a0V, Chateau\u00a0D, Bryson\u00a0GL et\u00a0al (2014) Timing of vasopressor initiation and mortality in septic shock: a\u00a0cohort study. Crit Care 18:R97","journal-title":"Crit Care"},{"key":"976_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1002\/emp2.12060","volume":"1","author":"LP Black","year":"2020","unstructured":"Black\u00a0LP, Puskarich\u00a0MA, Smotherman\u00a0C et\u00a0al (2020) Time to vasopressor initiation and organ failure progression in early septic shock. J\u00a0Am Coll Emerg Physicians Open 1:222\u2013230","journal-title":"J Am Coll Emerg Physicians Open"},{"key":"976_CR26","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1164\/rccm.201806-1034OC","volume":"199","author":"C Permpikul","year":"2019","unstructured":"Permpikul\u00a0C, Tongyoo\u00a0S, Viarasilpa\u00a0T et\u00a0al (2019) Early use of norepinephrine in septic shock resuscitation (CENSER). A randomized trial. Am J Respir Crit Care Med 199:1097\u20131105","journal-title":"Am J Respir Crit Care Med"},{"key":"976_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13054-021-03711-5","volume":"25","author":"I Adda","year":"2021","unstructured":"Adda\u00a0I, Lai\u00a0C, Teboul\u00a0JL et\u00a0al (2021) Norepinephrine potentiates the efficacy of volume expansion on mean systemic pressure in septic shock. Crit Care 25:302","journal-title":"Crit Care"},{"key":"976_CR28","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1007\/s00134-008-1219-0","volume":"34","author":"JA Myburgh","year":"2008","unstructured":"Myburgh\u00a0JA, Higgins\u00a0A, Jovanovska\u00a0A et\u00a0al (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226\u20132234","journal-title":"Intensive Care Med"},{"key":"976_CR29","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1378\/chest.12-1106","volume":"143","author":"SM Brown","year":"2013","unstructured":"Brown\u00a0SM, Lanspa\u00a0MJ, Jones\u00a0JP et al (2013) Survival after shock requiring high-dose vasopressor therapy. Chest 143:664\u2013671","journal-title":"Chest"},{"key":"976_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/SHK.0000000000000426","volume":"44","author":"C Martin","year":"2015","unstructured":"Martin\u00a0C, Medam\u00a0S, Antonini\u00a0F et\u00a0al (2015) Norepinephrine: not too much, too long. Shock 44:305\u2013309","journal-title":"Shock"},{"key":"976_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13613-017-0261-x","volume":"7","author":"T Auchet","year":"2017","unstructured":"Auchet\u00a0T, Regnier\u00a0MA, Girerd\u00a0N et al (2017) Outcome of patients with septic shock and high-dose vasopressor therapy. Ann Intensive Care 7:43","journal-title":"Ann Intensive Care"},{"key":"976_CR32","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.jpainsymman.2016.12.333","volume":"53","author":"DA Brand","year":"2017","unstructured":"Brand\u00a0DA, Patrick\u00a0PA, Berger\u00a0JT et al (2017) Intensity of vasopressor therapy for septic shock and the risk of in-hospital death. J\u00a0Pain Symptom Manage 53:938\u2013943","journal-title":"J Pain Symptom Manage"},{"key":"976_CR33","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s00134-018-5197-6","volume":"44","author":"SL Rygard","year":"2018","unstructured":"Rygard\u00a0SL, Butler\u00a0E, Granholm\u00a0A et al (2018) Low-dose corticosteroids for adult patients with septic shock: a\u00a0systematic review with meta-analysis and trial sequential analysis. Intensive Care Med 44:1003\u20131016","journal-title":"Intensive Care Med"},{"key":"976_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1056\/NEJMoa067373","volume":"358","author":"JA Russell","year":"2008","unstructured":"Russell\u00a0JA, Walley\u00a0KR, Singer\u00a0J et\u00a0al (2008) Vasopressin versus norepinephrine infusion in patients with septic shock. N\u00a0Engl J Med 358:877\u2013887","journal-title":"N Engl J Med"},{"key":"976_CR35","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/CCM.0000000000005317","volume":"50","author":"GL Sacha","year":"2022","unstructured":"Sacha\u00a0GL, Lam\u00a0SW, Wang\u00a0L et\u00a0al (2022) Association of catecholamine dose, lactate, and shock duration at vasopressin initiation with mortality in patients with septic shock. Crit Care Med 50:614\u2013623","journal-title":"Crit Care Med"},{"key":"976_CR36","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/MCC.0000000000000507","volume":"24","author":"KR Walley","year":"2018","unstructured":"Walley\u00a0KR (2018) Sepsis-induced myocardial dysfunction. Curr Opin Crit Care 24:292\u2013299","journal-title":"Curr Opin Crit Care"},{"key":"976_CR37","doi-asserted-by":"publisher","first-page":"1638","DOI":"10.1056\/NEJMoa1609409","volume":"375","author":"AC Gordon","year":"2016","unstructured":"Gordon\u00a0AC, Perkins\u00a0GD, Singer\u00a0M et\u00a0al (2016) Levosimendan for the prevention of acute organ dysfunction in sepsis. N\u00a0Engl J Med 375:1638\u20131648","journal-title":"N Engl J Med"}],"container-title":["Medizinische Klinik - Intensivmedizin und Notfallmedizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-022-00976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00063-022-00976-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00063-022-00976-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T14:02:40Z","timestamp":1699884160000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00063-022-00976-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,4]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1007\/s00063-022-00976-8","relation":{},"ISSN":["2193-6218","2193-6226"],"issn-type":[{"value":"2193-6218","type":"print"},{"value":"2193-6226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,4]]},"assertion":[{"value":"7 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>S.\u00a0Petros<\/b>: A.\u00a0Finanzielle Interessen: S.\u00a0Petros gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Internist, Intensivmediziner, H\u00e4mostaseologe; Leiter Interdisziplin\u00e4re Internistische Intensivmedizin, Universit\u00e4tsklinikum Leipzig; Leiter Bereich H\u00e4mostaseologie, Medizinische Klinik und Poliklinik\u00a01, Universit\u00e4tsklinikum Leipzig; Leiter Zentrum f\u00fcr H\u00e4mostaseologie, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Internistische Intensivmedizin und Notfallmedizin, Deutsche Interdisziplin\u00e4re Vereinigung f\u00fcr Intensiv- und Notfallmedizin, European Society of Intensive Care Medicine, International Society on Thrombosis and Haemostasis.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von dem Autor keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}